Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Change in Directorate

Dear Sir/Madam, We hereby inform you that pursuant to Regulations 30(5) & 30(6) read with Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Mr. Deepesh Shah has been appointed as an Independent Director of the Company w.e.f. 22.04.2022. Kindly take the same on record.
22-04-2022
Bigul

Medico Remedies Ltd - 540937 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2022

We hereby submit Compliance Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended 31st March, 2022.
06-04-2022
Bigul

Medico Remedies Ltd - 540937 - Compliance Certificate For The Year Ended 31St March, 2022

We hereby submit the duly signed Compliance Certificate for the year ended on 31st March, 2022 pursuant to Regulation 7(3) of the SEBI (LODR) Regulations, 2015.
06-04-2022
Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended March 2022

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- HARESH MEHTADesignation :- Managing Director / Whole Time Director
04-04-2022
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended & Company''s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, the ''Trading Window'' for dealing in the equity shares of the Company is closed, for all Insiders, Designated Persons and their immediate relatives, from 1st April, 2022 up to the expiry of 48 hours post the date of declaration of the Audited Financial Results for the year ended March 31st , 2022.
31-03-2022
Bigul

Medico Remedies Ltd - 540937 - Shareholding for the Period Ended December 31, 2021

Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
13-01-2022
Bigul

Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended December 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- HARESH MEHTADesignation :- Managing Director / Whole Time Director
11-01-2022
Bigul

Medico Remedies Ltd - 540937 - Unaudited Financial Results For The Half Year Ended 30Th September, 2021

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 12th November, 2021 has, inter alia considered and approved the Unaudited Financial Results for the half year ended 30th September, 2021 alongwith Auditors' Limited Review Report thereon
12-11-2021
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors at their Meeting held today i.e. 12th November, 2021 has, inter alia considered and approved the Unaudited Financial Results for the half year ended 30th September, 2021 alongwith Auditors' Limited Review Report thereon
12-11-2021
Next Page
Close

Let's Open Free Demat Account